Evidence map›Paper›PMID 42839614›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026

Modulation of Presynaptic Inhibitory Retinal Circuits for Retinal Ganglion Cell Neuroprotection in Glaucoma.

Eunji Hong, Chen Lin, Wenjie Long, Ian Kim, Mengwen Xiong, Zuer Wu, Siyuan Rao, Qianbin Wang

Abstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Eunji HongDepartment of Biomedical Engineering, Binghamton University, State University of New York, Binghamton, New York, USA.ORCID https://orcid.org/0000-0003-3294-1780
Chen LinDepartment of Biomedical Engineering, Binghamton University, State University of New York, Binghamton, New York, USA.ORCID https://orcid.org/0009-0009-6481-2730
Wenjie LongDepartment of Biomedical Engineering, Binghamton University, State University of New York, Binghamton, New York, USA.ORCID https://orcid.org/0009-0005-2000-1267
Ian KimDepartment of Biomedical Engineering, Binghamton University, State University of New York, Binghamton, New York, USA.ORCID https://orcid.org/0009-0007-4068-2105
Mengwen XiongDepartment of Biomedical Engineering, Binghamton University, State University of New York, Binghamton, New York, USA.ORCID https://orcid.org/0009-0004-1758-2294
Zuer WuDepartment of Biomedical Engineering, Binghamton University, State University of New York, Binghamton, New York, USA.ORCID https://orcid.org/0009-0003-1621-0459
Siyuan RaoDepartment of Biomedical Engineering, Binghamton University, State University of New York, Binghamton, New York, USA.ORCID https://orcid.org/0000-0002-1555-487X
Qianbin WangDepartment of Biomedical Engineering, Binghamton University, State University of New York, Binghamton, New York, USA.ORCID https://orcid.org/0000-0002-9840-6732

Funding

Magnetic Modulation on Targeted Neural Circuits in AutismR00MH120279 · NIMH · UNIVERSITY OF MASSACHUSETTS AMHERST · PI RAO, SIYUAN · 2021 to 2023
$747k
Identifying Cellular Intraspinal Electrophysiological Features of "Spinal Shock"R21NS144777 · NINDS · STATE UNIVERSITY OF NY,BINGHAMTON · PI HE, ZHIGANG, RAO, SIYUAN · 2025 to 2025
$470k
Motion Adaptive Neural Interfaces for Brain-Body CommunicationF31NS151910 · NINDS · STATE UNIVERSITY OF NY,BINGHAMTON · PI Chen Lin · 2026 to 2026
$44k
Air Force Office of Scientific Research Young Investigator Program FA9550-23-1-0339Binghamton UniversityBinghamton University S3IP Small Grant ADLG267Binghamton University S3IP Small Grant ADLG274Binghamton University Transdisciplinary Areas of Excellence (TAE) programBinghamton University Watson College of Engineering and Applied Science Seed Grant Program 105383Brain & Behavior Research Foundation Young Investigator 29878Craig H. Neilsen Foundation 1348565National Science Foundation Faculty Early Career Development Program 2414753National Science Foundation Faculty Early Career Development Program 2442112NIH HHS F31NS151910NIH HHS R00MH120279NIH HHS R21NS144777NIMH NIH HHS R00 MH120279NINDS NIH HHS F31 NS151910NINDS NIH HHS R21 NS144777
6 · The paper itself

Abstract

Glaucoma is a leading cause of irreversible blindness, yet the circuit-level mechanisms contributing to retinal ganglion cell (RGC) degeneration remain incompletely defined. Although multiple neuroprotective strategies have been explored, clinical translation remains limited. Here, we identify early dysfunction of inner retinal inhibitory circuitry as a modifiable contributor to RGC vulnerability during ocular hypertensive stress. In mouse ocular hypertension models, inner nuclear layer neurons exhibited increased c-fos expression and enhanced oscillatory potential-associated differential electroretinography signals before substantial RGC loss was detected, suggesting early retinal circuit hyperactivity. Broad pharmacological attenuation of GABAergic and glycinergic inhibitory signaling improved RGC survival without reducing intraocular pressure, supporting a functional contribution of inhibitory neurotransmission to RGC vulnerability. Moreover, Cre-dependent AAV delivery of Lin28, an RNA-binding regulator of post-transcriptional gene expression, to Vgat-positive inhibitory interneurons increased RGC survival compared with Vgat-EGFP controls and Vglut2-lineage Lin28 expression. Vgat-targeted Lin28 also reduced c-fos expression and oscillatory potential-associated differential electroretinogram abnormalities, indicating suppression of ocular hypertension-associated inner retinal hyperactivity. In addition, ocular hypertension was associated with altered sleep architecture, and Vgat-targeted Lin28 expression was associated with mitigation of these alterations. These findings position presynaptic inhibitory retinal circuitry as an early and modifiable contributor to glaucomatous RGC vulnerability.

Indexed as

glaucomainhibitory retinal circuitsLin28ocular hypertensionretinal ganglion cells

Identifiers

PMID42839614
PMCPMC13643093

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.